✦ LIBER ✦

Genetic and epigenetic inactivation of LPL gene in human prostate cancer

✍ Scribed by Jin Woo Kim; Yu Cheng; Wennuan Liu; Tao Li; Srinivasan Yegnasubramanian; Siqun L. Zheng; Jianfeng Xu; William B. Isaacs; Bao-Li Chang

Publisher: John Wiley and Sons
Year: 2009
Tongue: French
Weight: 196 KB
Volume: 124
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.23972

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Lipoprotein lipase (LPL) is in chromosome 8p22, site of one of the most common somatic deletions in prostate tumors. Additionally, a CpG island (CGI) was identified in the LPL promoter region. To test the hypothesis that LPL is a tumor suppressor gene, which is inactivated by somatic deletion and hypermethylation in prostate cancer, we evaluated somatic DNA deletion and methylation status at LPL in 56 pairs of DNA samples isolated from prostate cancer tissues and matching normal controls and 11 prostate cell lines. We found that the DNA in 21 of 56 primary cancers (38%) was methylated in the LPL promoter CGI, whereas no methylation was detected in any normal samples. In addition, we found a hemizygous deletion at LPL in 38 of the 56 tumors (68%). When the results of deletion and methylation were considered together, we found LPL promoter CGI methylation occurred in 45% of LPL deleted tumors and in 22% of LPL retained tumors. Within several clinical characteristics tested, the preoperative PSA levels were found to be significantly higher in subjects with LPL promoter CGI methylation compared with subjects without LPL promoter methylation (p = 0.0012). Additionally, demethylation of the LPL promoter CGI was accompanied by transcriptional reactivation of LPL in the prostate cancer cell lines DU145 and PC3. In summary, we report a novel finding that the LPL gene is commonly methylated in prostate tumors, and our results suggest that biallelic inactivation of LPL by chromosomal deletion and promoter hypermethylation may play a role in human prostate cancer. © 2008 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Genetic and epigenetic inactivation of L

Genetic and epigenetic inactivation of LTF gene at 3p21.3 in lung cancers

✍ Hironobu Iijima; Yoshio Tomizawa; Yasuki Iwasaki; Koji Sato; Noriaki Sunaga; Kun 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 French ⚖ 223 KB 👁 1 views

## Abstract Allelic loss on the short arm of chromosome 3 is one of the most common events in the pathogenesis of lung cancer. The lactotransferrin gene (__LTF,__ also referred to as the lactoferrin gene, __LF__) is located at 3p21.3 common eliminated region 1, which is frequently deleted in lung a

Genetic and epigenetic inactivation of t

Genetic and epigenetic inactivation of tax gene in adult T-cell leukemia cells

✍ Satoshi Takeda; Michiyuki Maeda; Shigeru Morikawa; Yuko Taniguchi; Jun-ichirou Y 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 French ⚖ 273 KB 👁 1 views

## Abstract To clarify the status of __tax__ gene, we analyzed human T‐cell leukemia virus type‐I (HTLV‐I) associated cell lines and fresh adult T‐cell leukemia (ATL) cells. We compared 2 types of HTLV‐I associated cell lines: one was derived from leukemic cells (leukemic cell line) and the other f

Epigenetic inactivation of TSLC1 gene in

Epigenetic inactivation of TSLC1 gene in nasopharyngeal carcinoma

✍ Angela Bik-Yu Hui; Kwok-Wai Lo; Joseph Kwong; Eric Ching-Wan Lam; Sylvia Yat-Yee 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 294 KB

## Abstract Deletion of 11q23 is a common genetic aberration in nasopharyngeal carcinoma (NPC). Multiple candidate tumor suppressor genes (TSG) were mapped to this region but few of them were investigated in NPC. __TSLC1__ (tumor suppressor in lung cancer) is recently reported to be a putative TSG

Epigenetic inactivation of the deleted i

Epigenetic inactivation of the deleted in lung and esophageal cancer 1 gene in nasopharyngeal carcinoma

✍ Joseph Kwong; Lillian Shuk-Nga Chow; Albert Yue-Hang Wong; Wing-Ki Hung; Grace T 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 478 KB 👁 1 views

## Abstract Deletion of the short arm of chromosome 3 is a common event in nasopharyngeal carcinoma (NPC), suggesting that one or more tumor suppressor genes at 3p are involved in this cancer. __DLEC1__, Deleted in Lung and Esophageal Cancer 1, located at 3p22.2, was recently identified as a candid

Epigenetic silencing of maspin gene expr

Epigenetic silencing of maspin gene expression in human breast cancers

✍ Frederick E. Domann; Judd C. Rice; Mary J.C. Hendrix; Bernard W. Futscher 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 French ⚖ 135 KB 👁 2 views

Maspin is a tumor suppressor whose expression is lost in many advanced breast cancers. Maspin has been shown to inhibit cell motility, invasion and metastasis; however, its precise role in normal mammary epithelium remains to be elucidated. Although expression of maspin mRNA is low or absent in most

Frequent epigenetic inactivation of Myoc

Frequent epigenetic inactivation of Myocardin in human nasopharyngeal carcinoma

✍ Fu Chen; Yingxi Mo; Hao Ding; Xue Xiao; Shu Yi Wang; Guangwu Huang; Zhe Zhang; S 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 253 KB

## Abstract ## Background Epigenetic silencing of tumor suppressor genes plays an important role in nasopharyngeal carcinoma (NPC) tumorigenesis. In the present study, we explore a novel target gene of epigenetic silencing in NPC, __Myocardin__, which is inactivated by promoter hypermethylation.